Overview of Obesity
Run the List
00:00
Non-GLP-1 pharmacotherapy overview
Brooke summarizes older FDA-approved agents and off-label options typically yielding about 5% weight loss.
Play episode from 09:10
Transcript
Brooke summarizes older FDA-approved agents and off-label options typically yielding about 5% weight loss.
